MedPath

Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population

Not Applicable
Completed
Conditions
Lens Opacity
Interventions
Dietary Supplement: Lycium Barbarum
Dietary Supplement: Starch
Registration Number
NCT01142960
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

With the rapid growing aging population, age-related eye diseases including cataract are becoming more prevalent. The demand for cataract surgery and post-surgical care posed enormous financial burdens to the government.

Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and neutralize the reactive oxygen species, thus provide a protective effect against cataract formation.

This study aims to determine the effects of Lycium barbarum Supplements on the progression of senile cataract in Hong Kong Chinese elderly.

Detailed Description

Please note that a manuscript for this study is being prepared. Detailed description will be provided after we come up with the final draft.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
238
Inclusion Criteria
  • Unlikely to have cataract surgery within 3 years
  • Presence of mild to moderate cataract in one or both eyes, graded by Lens Opacities Classification System III (LOCSIII).
  • logMAR acuity equivalent to Snellen acuity of 20/63 or better
  • no previous history and clinical signs of glaucoma by determining intraocular pressure using applanation Tonometry (no more than 22mmHg)
  • no ocular anomalies: amblyopia, binocular anomalies, ocular trauma
  • no history of eye surgery, laser treatment, iritis, retinal crystalline deposits, macular degeneration, or optic nerve diseases
  • no extended use of systemic or ocular corticosteroid drugs
  • no concurrent participation of other systemic or ocular drug intervention study
Exclusion Criteria
  • diabetes mellitus
  • renal failure
  • fat malabsorption syndrome
  • intestinal surgery history
  • chronic diarrhea
  • alcoholism
  • use of anticoagulants
  • regular use of nutritional supplements such as multi-vitamin, mineral and other antioxidant supplements (including Omega-3)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lycium BarbarumLycium BarbarumLycium Barbarum supplement
PlaceboStarchStarch
Primary Outcome Measures
NameTimeMethod
Lens Opacity Classification System III (LOCSIII)3 years
Secondary Outcome Measures
NameTimeMethod
Visual Acuity3 years

Trial Locations

Locations (1)

The Hong Kong Polytechnic University

🇭🇰

Hung Hom, Kowloon, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath